Yanxia Jiang

658 total citations
54 papers, 483 citations indexed

About

Yanxia Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yanxia Jiang has authored 54 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Yanxia Jiang's work include Renal cell carcinoma treatment (14 papers), Renal and related cancers (9 papers) and RNA modifications and cancer (6 papers). Yanxia Jiang is often cited by papers focused on Renal cell carcinoma treatment (14 papers), Renal and related cancers (9 papers) and RNA modifications and cancer (6 papers). Yanxia Jiang collaborates with scholars based in China, United States and Canada. Yanxia Jiang's co-authors include Yujun Li, Wenjuan Yu, Guoan Chen, Yuewei Wang, Hong Chang, Wang Jia, Li Zhao, Peng Zhang, Jia‐Guo Zhao and Zengliang Wang and has published in prestigious journals such as Oncogene, International Journal of Biological Macromolecules and Medicine.

In The Last Decade

Yanxia Jiang

51 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanxia Jiang China 13 211 146 136 118 107 54 483
Yongqian Jia China 13 343 1.6× 88 0.6× 149 1.1× 52 0.4× 137 1.3× 43 587
Chihao Zhang China 19 182 0.9× 180 1.2× 142 1.0× 210 1.8× 175 1.6× 45 610
M Paesmans Belgium 5 159 0.8× 196 1.3× 75 0.6× 46 0.4× 225 2.1× 6 455
Helin Feng China 15 238 1.1× 144 1.0× 197 1.4× 79 0.7× 130 1.2× 47 557
Boyang Chang China 12 142 0.7× 94 0.6× 76 0.6× 90 0.8× 224 2.1× 26 458
Francesca Maria Tumminello Italy 14 278 1.3× 62 0.4× 176 1.3× 34 0.3× 187 1.7× 17 575
Zhiqiang Yin China 13 173 0.8× 90 0.6× 91 0.7× 138 1.2× 79 0.7× 32 484
Bao‐Shan Hu China 16 162 0.8× 111 0.8× 165 1.2× 163 1.4× 159 1.5× 60 708
Emiko Mori Japan 10 76 0.4× 111 0.8× 119 0.9× 179 1.5× 281 2.6× 25 540
Yifeng Sun China 16 254 1.2× 223 1.5× 103 0.8× 182 1.5× 102 1.0× 58 701

Countries citing papers authored by Yanxia Jiang

Since Specialization
Citations

This map shows the geographic impact of Yanxia Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Jiang more than expected).

Fields of papers citing papers by Yanxia Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxia Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Jiang. The network helps show where Yanxia Jiang may publish in the future.

Co-authorship network of co-authors of Yanxia Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxia Jiang. A scholar is included among the top collaborators of Yanxia Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxia Jiang. Yanxia Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yanxia, Wen Chen, Ming Luo, et al.. (2025). Phosphorylation of USP32 by CDK5 regulates Rap1 stability and therapeutic resistance in pancreatic ductal adenocarcinoma. Oncogene. 44(30). 2634–2645.
2.
Zhuo, Min, et al.. (2025). Multiomics analysis of O‐GlcNAcylation in podocytes of diabetic kidney disease. Diabetes Obesity and Metabolism. 27(5). 2708–2719. 3 indexed citations
3.
Jiang, Yanxia, et al.. (2025). Okra polysaccharide activates PPAR-γ signaling to attenuate metabolic-associated fatty liver disease in mice. International Journal of Biological Macromolecules. 321(Pt 3). 146449–146449. 1 indexed citations
4.
Liu, Jiao, Yuewei Wang, Xin Wang, et al.. (2024). Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma. Pathology - Research and Practice. 261. 155459–155459. 1 indexed citations
5.
Ding, Xiaoyan, Xiaoxia Li, Yanxia Jiang, et al.. (2024). RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway. Cancer Cell International. 24(1). 8 indexed citations
6.
Wang, Yunyun, et al.. (2023). Identification of hub genes associated with osteoporosis development by comprehensive bioinformatics analysis. Frontiers in Genetics. 14. 1028681–1028681. 5 indexed citations
7.
8.
Zhong, Hao, Tongyu Wang, Yulong Tian, et al.. (2023). Deep Learning Radiomics Nomogram Based on Enhanced CT to Predict the Response of Metastatic Lymph Nodes to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Annals of Surgical Oncology. 31(1). 421–432. 14 indexed citations
9.
Zhao, Peng, Lili Wang, Jigang Wang, et al.. (2022). Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma. Pathology - Research and Practice. 235. 153960–153960. 14 indexed citations
10.
Fang, Zhi, et al.. (2022). Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. Journal of Cancer. 13(6). 1808–1819. 4 indexed citations
11.
Zhang, Wei, Qian Zhang, Chao Zhu, et al.. (2022). The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer. Journal of Translational Medicine. 20(1). 558–558. 3 indexed citations
13.
Wang, Han & Yanxia Jiang. (2021). SRp20: A potential therapeutic target for human tumors. Pathology - Research and Practice. 224. 153444–153444. 4 indexed citations
14.
Jiang, Yanxia, et al.. (2021). Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients. World Journal of Clinical Cases. 9(29). 8694–8701. 2 indexed citations
15.
Zhang, Wei, Wenjuan Yu, Qiang Wang, Yanxia Jiang, & Yujun Li. (2015). The clinicopathological, ultrastructural, genetic features and diagnosis of small cell variant renal oncocytoma. Acta Histochemica. 117(6). 505–511. 5 indexed citations
16.
Fang, Yi, et al.. (2014). Somatic mutations of the HER2 in metastatic breast cancer. Tumor Biology. 35(12). 11851–11854. 10 indexed citations
17.
Wang, Yuewei, et al.. (2014). Primary intravascular large B cell lymphoma of the endometrium. Acta Histochemica. 116(5). 993–996. 4 indexed citations
18.
Zhao, Jia‐Guo, Li Zhao, Yanxia Jiang, et al.. (2014). Platelet‐Rich Plasma in Arthroscopic Rotator Cuff Repair: A Meta‐analysis of Randomized Controlled Trials. Arthroscopy The Journal of Arthroscopic and Related Surgery. 31(1). 125–135. 68 indexed citations
19.
Yang, Guangjie, et al.. (2011). Tc-99m MDP Uptake in a Giant Pulmonary Chondroma. Clinical Nuclear Medicine. 36(11). 1029–1030. 11 indexed citations
20.
Jiang, Yanxia. (2006). Small cell carcinoma of the prostate (report of 2 cases and review of the literature). Zhonghua miniao waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026